1. Home
  2. RNR vs PEN Comparison

RNR vs PEN Comparison

Compare RNR & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenaissanceRe Holdings Ltd.

RNR

RenaissanceRe Holdings Ltd.

HOLD

Current Price

$294.12

Market Cap

12.6B

Sector

Finance

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$335.57

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNR
PEN
Founded
1993
2004
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6B
13.2B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
RNR
PEN
Price
$294.12
$335.57
Analyst Decision
Hold
Buy
Analyst Count
16
17
Target Price
$307.14
$357.33
AVG Volume (30 Days)
348.7K
566.6K
Earning Date
01-01-0001
05-26-2026
Dividend Yield
0.55%
N/A
EPS Growth
N/A
1155.56
EPS
N/A
4.52
Revenue
N/A
$1,403,665,000.00
Revenue This Year
N/A
$14.20
Revenue Next Year
$3.25
$13.60
P/E Ratio
$5.42
$74.11
Revenue Growth
N/A
17.50
52 Week Low
$219.00
$221.26
52 Week High
$315.88
$362.41

Technical Indicators

Market Signals
Indicator
RNR
PEN
Relative Strength Index (RSI) 48.39 43.41
Support Level $235.78 $302.19
Resistance Level $312.68 $344.07
Average True Range (ATR) 6.77 2.39
MACD -1.95 -0.93
Stochastic Oscillator 30.45 18.85

Price Performance

Historical Comparison
RNR
PEN

About RNR RenaissanceRe Holdings Ltd.

RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: